![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, April 09, 2014 5:11:09 PM
Seems to be a great opportunity for a massive short squeeze...but, who knows. Just keeps drifting lower and lower since the last announcement. Almost looks like a replay after the 9/20/13 news if you look at a chart (which is just dumb, since this was good news).
Anyway, I guess they need to announce some "statistically significant" news about one of their trials...since "clinically meaningful" isn't good enough........
Everyone is abuzz over at SRPT lately that news about FDA approval (blah, blah, blah) is imminent for their drug. If that turns out not to be true, could give RNA a boost. At this point, it's all a guess.
Recent RNA News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2024 08:46:34 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/15/2024 08:43:54 PM
- Avidity Biosciences Announces Pricing of Upsized Public Offering of Common Stock • PR Newswire (US) • 08/15/2024 12:30:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/13/2024 08:20:11 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 09:12:23 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/09/2024 09:02:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 08:23:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:20:45 PM
- Avidity Biosciences Reports Second Quarter 2024 Financial Results and Recent Highlights • PR Newswire (US) • 08/09/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 11:02:28 AM
- Avidity Biosciences Announces Positive AOC 1044 Data Demonstrated Significant Increase of 25% in Dystrophin Production and Reduction of Creatine Kinase Levels to Near Normal in People Living with Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping in • PR Newswire (US) • 08/09/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 09:46:57 PM
- Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 08/05/2024 01:15:00 PM
- Avidity Biosciences Announces Appointment of John B. Moriarty, Jr. as Chief Legal Officer • PR Newswire (US) • 08/05/2024 01:00:00 PM
- Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 07/22/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 08:07:00 PM
- Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 06/21/2024 08:05:00 PM
- Avidity Biosciences Partners with the FSHD Society to Raise Awareness of Facioscapulohumeral Muscular Dystrophy on World FSHD Day • PR Newswire (US) • 06/20/2024 01:00:00 PM
- Avidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares • PR Newswire (US) • 06/17/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 11:06:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 10:58:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 10:56:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 10:54:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 09:05:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 08:58:23 PM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM